Drug Database
HO

Hoe-285 (Hoe 285 / Brainorm / Albex 285)

✓ Approved

Sanofi S.A · Small Molecule · Small Molecule

What is Hoe-285?

Hoe-285 is a small molecule developed by Sanofi S.A. It is approved for therapeutic indications via injectable (others) or intravenous (iv) or oral (po).

Drug Profile

Brand NamesHoe 285, Brainorm, Albex 285
CompanySanofi S.A
Drug ClassSmall Molecule
RouteInjectable (Others), Intravenous (IV), Oral (PO)
StatusApproved

Therapeutic Indications

Hoe-285 is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Nervous system disordersDelayed ischaemic neurological deficit✓ Approved

Related Research Articles

PubMedFood chemistry2026-07-25

Processing of watermelon seed shells nanocellulose with electron beam irradiation and esterification modification: Consequences on fundamental characteristics, molecular structure, physicochemical properties, functional performance, and associated mechanisms.

Guan Hanlin H, Niu Li L, Lin Qian Q, Ren Xiangrui X et al.

This study developed an electron beam irradiation (EBI)-assisted esterification strategy to convert underutilized watermelon seed shells into amphiphilic esterified nanocellulose (ENC). The multiscale structural evolution associated with EBI-enhanced esterification, as well as its feasibility for emulsion stabilization, was investigated. Native nanocellulose (NNC) was subjected to EBI (50, 100, 150 kGy) followed by lauric acid esterification. The degree of substitution of irradiated ENC was 0.28-0.77, which was 40-285% higher than unirradiated ENC (0.20). The decrease in hydrophilic-lipophilic balance indicated improved interfacial compatibility in nonpolar solvents. Fourier transform infrared spectroscopy confirmed successful lauric acid grafting. Transmission electron microscopy revealed that esterification induced nanocellulose to change from strip-like structures into aggregated particles (21.52-33.72 nm). Pickering emulsions prepared with ENC exhibited droplets (3.29-3.79 μm) and outstanding oxidative stability, underscoring ENC'S interfacial stabilization capability. This work integrates EBI-induced structural activation with lauric acid esterification, providing a new way to produce high-performance nanocellulose from agro-waste.

PubMedChemical science2026-07-25

Dihydrobenzofuro[3,2-b]benzofuran: a light-driven molecular switch with fluorescence switching, bistability, and intrinsic chirality.

Hassan Fathy F, Velmurugan Nivedha N, Tan Jingyun J, Yi Yuan-Qiu-Qiang YQ et al.

Designing photochromic materials with thermally stable bistability, fluorescence switching, and structural responsiveness remains a key challenge in responsive materials. In this study, we introduce photochromic behavior in 4b,9b-dihydrobenzofuro[3,2-b]benzofuran derivatives (DHBs). Guided by bond dissociation energies, we demonstrate that DHB derivatives undergo a reversible, light-induced regioselective ring-opening reaction accompanied by significant changes in structural, electronic, and photophysical properties. Upon UV illumination at 285 nm, the non-conjugated, weakly emissive closed-ring DHB undergoes a regioselective ring-opening to yield a conjugated, hydroxy-functionalized isomer that exhibits strong fluorescence. The reverse ring-closure occurs under 325 nm light, with no observable thermal back reaction, establishing a thermally stable, bistable molecular switch. The rigid, fused structure of DHB possesses intrinsic chirality, as confirmed by single-crystal X-ray diffraction revealing racemic twin crystals with nearly equal enantiopure domains. Enantiomeric separation by chiral HPLC enables the study of its stereochemical and chiroptical properties. Spectroscopic analyses, in both solution and thin films, together with DFT calculations, elucidate photoinduced fluorescence switching behavior, distinct HOMO-LUMO energy levels, and structural transformations between the two isomers. Notably, asymmetric substitution directs the site of bond cleavage, providing a handle to control photochemical reaction pathways. These results highlight the potential of DHB derivatives as a multifunctional photochromic scaffold and open new opportunities for the design of responsive materials with tunable optical and electronic properties.

PubMedEndoscopic ultrasound2026-07-25

Superiority of long-term outcomes of EUS-guided gastroenterostomy over endoscopic stenting for the palliation of malignant gastric outlet obstruction: A prospective cohort study.

Kuo Yu-Ting YT, Chang Sheng-Jie SJ, Lin Hung-Yao HY, Lin Tung-Yen TY et al.

Limited prospective data exist comparing long-term outcomes of endoscopic placement of a self-expandable metallic stent (ES) and EUS-guided gastroenterostomy (EUS-GE) for unresectable malignant gastric outlet obstruction (mGOO). This large-scale study aimed to prospectively compare these 2 procedures with long-term follow-up. This single-center, prospective study enrolled 152 consecutive patients with unresectable mGOO who underwent ES (n = 76) or EUS-GE (n = 76) between August 2021 and January 2024, with follow-up until death or administrative censoring on January 31, 2025. The primary outcome was the reintervention rate, while secondary outcomes included technical and clinical success, changes in the gastric outlet obstruction score (GOOS), adverse events (AEs), and survival. A Cox regression model identified factors associated with reintervention and survival. Both groups had comparable technical and clinical success rates and AEs. After a median follow-up of 121 days (interquartile range, 55-285), the EUS-GE group had a significantly lower reintervention (adjusted hazard ratio, 0.22, P < 0.001), longer stent patency (median, 566 days vs. 195 days; P < 0.001), and greater GOOS improvement (median, 3 vs. 2; P < 0.001) compared with the ES group. Poor performance status, the presence of ascites, and lack of chemotherapy were independent mortality risk factors. Compared with ES, EUS-GE provides longer stent patency, fewer reinterventions, and better relief of GOO symptoms while maintaining a similar safety profile. In an expert setting, EUS-GE should be considered the optimal approach for managing unresectable mGOO, as it offers superior short- and long-term outcomes.

PubMedCarbohydrate polymers2026-07-24

Corrigendum to "Heparan sulfate from porcine mucosa promotes amyloid-beta clearance in APP/PS1 mice and alleviates Alzheimer's pathology" [Carbohydrate Polymers 285 (2022) 119205].

Wu Lidan L, Jiang Wenjie W, Zhao Na N, Wang Fengshan F

PubMedJACC. Asia2026-07-24

TNNT2 Mutation Affects the Progression of Dilated Cardiomyopathy in Children.

Liu Shun S, Mo Han H, Chen Xiao X, Cui Hao H et al.

Genetic mutations play an important role in pediatric cardiomyopathy. However, whether different genetic factors contribute to the rate of disease progression remains unclear. To explore the role of genetic mutations in disease progression in pediatric cardiomyopathy. We collected basic clinical data on 67 children and 166 adults who underwent heart transplantation for cardiomyopathy, and conducted whole-exome sequencing and standard pathology examinations on these patients. We then compared the prevalence of pathogenic genes and their occurring in the same type of myocardium between children and adult heart transplantation recipients, with a focus on the age of onset and duration of disease. Of 67 children, 33 (49.3%; 95% CI: 32.2%-55.3%) carried mutation genes. The proportion of mutations varied significantly among different types of cardiomyopathies (P = 0.003). The median [IQR] time from diagnosis to transplant was significantly shorter in children compared to adults in cases of dilated cardiomyopathy (DCM) (12 [1-23] vs 103 [5-201] months, P < 0.001), hypertrophic cardiomyopathy (32 [14.5-46.5] vs 234 [183-285] months, P = 0.002) and arrhythmogenic cardiomyopathy (28 [14.5-41.5] vs 127 [86-168] months, P < 0.001). Children with DCM were more likely to carry the TNNT2 mutation compared to adults with DCM (P = 0.001), and heart failure progressed more rapidly in children with this mutation versus adults (19 vs 128 months, P = 0.002). The most common mutation site in these children was p.K220del. TNNT2 mutations were associated with shorter time from diagnosis to transplantation in children with DCM. These findings suggest that early genetic evaluation may aid in risk stratification and inform clinical management in pediatric cardiomyopathy.

PubMedAnalytical and bioanalytical chemistry2026-07-24

Validated SPE-HPLC-MS/MS analysis of steroid hormones in H295R cell culture medium: chromatographic separation and ESI response in the presence of potential endocrine-disrupting chemicals.

Sadutto Daniele D, Manna Livia L, Tait Sabrina S, Coppola Lucia L et al.

A sensitive and robust SPE-HPLC-MS/MS method was developed and validated for the simultaneous quantification of five steroid hormones in H295R cell culture medium. Chromatographic separation of the target steroids and selected potential endocrine‑disrupting chemicals (EDCs) was achieved using a ZORBAX Eclipse Plus C18 column (1.8 µm, 95 Å, 50 × 2.1 mm). Sample preparation was performed by solid‑phase extraction employing hydrophilic-lipophilic balanced polymeric reversed‑phase sorbent cartridges. Extraction recovery was evaluated at three concentration levels, tailored to each steroid, and exceeded 80% for all analytes. Intra‑ and inter‑day precision, expressed as relative standard deviation (RSD), ranged from 1 to 12%. Method limits of quantification were in the range of 8 and 73 pg mL⁻1, enabling reliable detection of steroids present at low endogenous levels. In addition to method validation, the ESI response of steroids was systematically evaluated in the presence of the selected compounds. Under the reference chromatographic gradient, signal variations were generally limited, indicating stable and robust ionization performance during LC-ESI-MS/MS analysis. The validated method was successfully applied to the high-throughput analysis of 285 H295R cell culture medium samples, generating a dataset of 1425 individual hormone measurements obtained within a broader framework investigating steroidogenic responses to individual potential EDCs. The results confirmed the capability of the analytical method to reliably monitor hormone fluctuations across a broad concentration range, demonstrating its suitability for routine, large-scale sample analysis in complex in vitro systems.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about Hoe-285